Cargando…
P53 rs1042522 and CD95 rs1800682 genetic variations in HCV-4a response to antiviral therapy
Current estimates indicate that the hepatitis C (HCV) is the leading cause of mortality around the world, with infection rates steadily increasing in Egypt. The dual therapy for this silent epidemic with pegylated-interferon-α2b/ribavirin has markedly improved the success rates in genotype-4 patient...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Chongqing Medical University
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150111/ https://www.ncbi.nlm.nih.gov/pubmed/30258864 http://dx.doi.org/10.1016/j.gendis.2015.02.004 |